Achieve Life Sciences, Inc.

NasdaqCM:ACHV Stock Report

Market Cap: US$127.2m

Achieve Life Sciences Management

Management criteria checks 0/4

Achieve Life Sciences' CEO is Rick Stewart, appointed in Aug 2024, has a tenure of less than a year. total yearly compensation is $1.35M, comprised of 33.3% salary and 66.7% bonuses, including company stock and options. directly owns 0.15% of the company’s shares, worth $189.57K. The average tenure of the management team and the board of directors is 0.7 years and 2.8 years respectively.

Key information

Rick Stewart

Chief executive officer

US$1.4m

Total compensation

CEO salary percentage33.3%
CEO tenureless than a year
CEO ownership0.1%
Management average tenureless than a year
Board average tenure2.8yrs

Recent management updates

Recent updates

Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement

Jul 01

Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?

Jan 27
Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?

Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?

Oct 26
Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?

Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?

Mar 26
Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?

Achieve Life Sciences begins phase 2 trial testing cytisinicline for nicotine e-cigarette cessation

Jun 29

Achieve Life Sciences: Initiating Buy, Potential Multi-Billion-Dollar Smoking Cessation Drug

Apr 04

Is Achieve Life Sciences (NASDAQ:ACHV) Weighed On By Its Debt Load?

Mar 22
Is Achieve Life Sciences (NASDAQ:ACHV) Weighed On By Its Debt Load?

Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Deliver On Growth Plans?

Sep 27
Is Achieve Life Sciences (NASDAQ:ACHV) In A Good Position To Deliver On Growth Plans?

We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully

Jun 14
We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Achieve Life Sciences' (NASDAQ:ACHV) Cash Burn Rate

Mar 01
We're Keeping An Eye On Achieve Life Sciences' (NASDAQ:ACHV) Cash Burn Rate

Achieve Life Sciences prices stock offering at $7; shares down 2%

Dec 03

Achieve Life Sciences launches equity offering

Nov 30

CEO Compensation Analysis

How has Rick Stewart's remuneration changed compared to Achieve Life Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$33m

Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$27m

Dec 31 2023US$1mUS$450k

-US$30m

Sep 30 2023n/an/a

-US$36m

Jun 30 2023n/an/a

-US$42m

Mar 31 2023n/an/a

-US$44m

Dec 31 2022US$1mUS$400k

-US$42m

Sep 30 2022n/an/a

-US$38m

Jun 30 2022n/an/a

-US$32m

Mar 31 2022n/an/a

-US$33m

Dec 31 2021US$1mUS$400k

-US$33m

Sep 30 2021n/an/a

-US$31m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$19m

Dec 31 2020US$1mUS$474k

-US$15m

Sep 30 2020n/an/a

-US$13m

Jun 30 2020n/an/a

-US$13m

Mar 31 2020n/an/a

-US$14m

Dec 31 2019US$797kUS$500k

-US$16m

Sep 30 2019n/an/a

-US$17m

Jun 30 2019n/an/a

-US$16m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$1mUS$500k

-US$13m

Compensation vs Market: Rick's total compensation ($USD1.35M) is above average for companies of similar size in the US market ($USD645.47K).

Compensation vs Earnings: Rick's compensation has increased whilst the company is unprofitable.

CEO

Rick Stewart (65 yo)

less than a year

Tenure

US$1,350,905

Compensation

Dr. Richard A. B. Stewart, also known as Rick, had been an Executive Chairman at Achieve Life Sciences, Inc. since September 28, 2020 until August 2024 and serves as its Chief Executive Officer from August...

Leadership Team

NamePositionTenureCompensationOwnership
Thomas King
Executive Chairman1.8yrsUS$281.35k0%
$ 0
Richard A. Stewart
CEO & Executive Directorless than a yearUS$1.35m0.15%
$ 189.6k
Cindy Jacobs
President4.3yrsUS$1.20m0.097%
$ 122.9k
Mark Oki
Chief Financial Officerless than a yearno datano data
Jerry Wan
Principal Accounting Officerno datano data0.037%
$ 46.9k
Anthony Clarke
Chief Scientific Officer7.4yrsUS$589.66kno data
Jaime Xinos
Chief Commercial Officer8yrsno data0.076%
$ 97.3k
Mark Rubinstein
Head of Medical Affairsless than a yearno datano data
Craig Donnelly
Executive Vice President of CMC & Regulatory CMCless than a yearno datano data

0.7yrs

Average Tenure

65.5yo

Average Age

Experienced Management: ACHV's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Thomas King
Executive Chairman1.8yrsUS$281.35k0%
$ 0
Richard A. Stewart
CEO & Executive Director8yrsUS$1.35m0.15%
$ 189.6k
Cindy Jacobs
President3.8yrsUS$1.20m0.097%
$ 122.9k
Vaughn Himes
Independent Director2.8yrsUS$195.82k0%
$ 0
Stuart Duty
Independent Director1.8yrsUS$270.60k0%
$ 0
Thomas Sellig
Independent Director1.8yrsUS$269.75k0%
$ 0
Bridget Martell
Independent Director3.8yrsUS$198.75k0%
$ 0

2.8yrs

Average Tenure

63yo

Average Age

Experienced Board: ACHV's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 02:32
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Achieve Life Sciences, Inc. is covered by 10 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCG Capital
Gary NachmanCGS International
Ilya ZubkovFreedom Broker